Austarpharma Inc Edison, NJ - 08837

Austarpharma Inc is categorized under Pharmaceutical Manufacturing Plant Construction in Edison, NJ and active since 2006.

Austarpharma Inc was established in 2006, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Pharmaceutical Manufacturing Plant Construction business, which does work in the B2B market, and is classified as a Pharmaceutical Manufacturing Plant Construction, under code number 236220 by the NAICS.

If you are seeking more information, feel free to contact Rong Liu at the company’s single location by writing to 18 Mayfield Avenue, Edison, New Jersey NJ 08837 or by phoning (732) 512-6525. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Austarpharma Inc
Contact Person: Rong Liu
Address: 18 Mayfield Avenue, Edison, New Jersey 08837
Phone Number: (732) 512-6525
Website Address: austarpharma.com
Annual Revenue (USD): $100.000 to $499.999
Founded: 2006
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Pharmaceutical Manufacturing Plant Construction
SIC Code: 1541
NAICS Code: 236220
Share This Business:

Austarpharma Inc was started in 2006 to provide professional Pharmaceutical Manufacturing Plant Construction under the SIC code 1541 and NAICS code 236220. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Rong Liu for inquiries that concern Austarpharma Inc by calling the company number (732) 512-6525, as your correspondence is most welcome. Additionally, the physical location of the single location of Austarpharma Inc can be found at the coordinates 40.507736,-74.345441 as well as the street address 18 Mayfield Avenue in Edison, New Jersey 08837.

For its online presence, you may visit Austarpharma Inc’s website at austarpharma.com and engage with its social media outlets through on Twitter and on Facebook.